Xtx Topco LTD Adverum Biotechnologies, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.75 - $1.26 $10,832 - $18,198	14,443 Added 39.4%	51,100 $38,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.33 $30,487 - $47,357	20,325 Added 124.45%	36,657 $54,000
Q2 2023 Aug 14, 2023	BUY	$0.68 - $1.59 $11,105 - $25,967	16,332 New	16,332 $25,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $90,528 - $912,824	94,300 Added 249.67%	132,070 $125,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $1.34 $30,593 - $50,611	37,770 New	37,770 $45,000
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $35,804 - $56,762	-29,109 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.74 - $2.4 $50,649 - $69,861	29,109 New	29,109 $51,000

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $689M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.